Integrated with the prognostic information of 877 CRC patients, we developed the five-GMRHG (ACOX1, ATOH1, CPT2, PCSK5, and TINCR) prognostic signature to conduct stratified prognostic analysis for CRC patients. This evidence concerns the gene ACOX1 and colorectal carcinoma.